Facebook announced it will convert part of its Menlo Park, California headquarters into a vaccination clinic for under-served communities. Read More
In a new analysis of its phase three trial in the United States, AstaZeneca has determined their COVID-19 vaccine to be 76% effective. This new data shows a three percent change from their initial report earlier this week stating their efficacy rate to be 79% effective against the coronavirus disease. AstraZeneca’s original filing came under public scrutiny from health officials in the United States because their data did not include more recent infections.
Crude has been the underdog since Covid-19 broke onto the scene in early March of 2020. We have seen historic contango, negative trading, inventories at the verge of 100% capacity. However, we have also seen refineries curtailing production and shutting down, crude breaking technical level after level, OPEC + committing to decreased outputs, a Texas winter weather creating supply concerns, and a slow steady recovery of crude as inventories are drawn down and production resumes. Crude has built a full head of steam and looks to be an unstoppable force and a surefire pick to rise to glory yet again for 2021. March Madness is known for its volatile emotional up and downs and surprise sleeper teams with unimaginable upsets. Will 2021 and a third European lockdown amid vaccine safety concerns be the sleeper to upset the rise of Crude?!
After a year of uncertainty and instability in the market created by COVID-19 and a global shutdown, we are starting to see signs of a return to normalcy. Over the past 8 weeks there has been a gradual decline in COVID-19 cases nationally. According to Bloomberg business, “retail gasoline sales rose last week to just 1% below year-ago levels, just before regional lockdowns brought fuel consumption to a crawl.”
As new variants of COVID-19 emerge, the Johnson & Johnson vaccine has been given the green light by the U.S. FDA for emergency use. This will be the first single shot vaccine released to fight COVID-19. As early as Tuesday morning, 3.9 million doses of the Johnson & Johnson vaccine will be distributed to states, tribes, territories, pharmacies, and community health centers. While the vaccine will be limited at first, Johnson & Johnson expects to increase production within the coming months. By the end of March, we should see an additional 16 million doses distributed. The company is committed to delivering 100 million doses by June and “up to a billion” by the end of 2021. Since their vaccine is one dose that will equate to as many people being treated as vaccinations.
This week the United States passed 500,000 Covid-19 related deaths, a devastating milestone. While we continue our fight against this global pandemic, there are signs that things will get better sooner rather than later. Today the FDA endorsed Johnson & Johnson’s Covid-19 vaccine for emergency use. This is welcomed news for the fight against Covid-19 and critical step in getting back to a sense of normalcy. With this endorsement this now brings a third vaccine to the U.S. marketplace with the Pfizer and Moderna vaccines already being rolled out.
President Biden announced Tuesday evening that the United States is aiming to purchase an additional 200 million does of COVID-19 vaccines. Securing these supplemental doses would be enough to inoculate most Americans by the end of the summer. The Biden Administration will purchase 100 million doses of each of the two current vaccines on the market, the Moderna vaccine and the vaccine created by Pfizer and BioNTech. This will be an overall increase to 600 million doses obtained by the United States.
Tis the season for winter weather and this week we are experiencing the full effects of winter storm Gail, marching up the east coast. Many from Washington D.C., Maryland, Virginia, West Virginia and Pennsylvania have all felt these effects which includes slick road conditions and delayed travel.
On December 14, 2020 the first batch of COVID-19 vaccines were administered across the United States after months of hearing positive trial results. Sandra Lindsay, a nurse in the intensive care unit at Long Island Jewish Medical Center, was the first person to receive the vaccine outside the trial phase. Lindsay’s vaccination was televised in an effort to instill faith in the vaccine and its legitimacy. Lindsay stated, “I think also as a leader in the organization that I lead by example. I don’t ask people to do anything that I would not do myself”. New York felt the force of this virus heavily as it left over 35,000 people dead and dampened the economy quite a bit. With the COVID-19 related death count exceeding 300,000 nationwide, this vaccine has been highly anticipated.